ES2196149T3 - Preparaciones purgantes no acuosas para el colon. - Google Patents

Preparaciones purgantes no acuosas para el colon.

Info

Publication number
ES2196149T3
ES2196149T3 ES96915636T ES96915636T ES2196149T3 ES 2196149 T3 ES2196149 T3 ES 2196149T3 ES 96915636 T ES96915636 T ES 96915636T ES 96915636 T ES96915636 T ES 96915636T ES 2196149 T3 ES2196149 T3 ES 2196149T3
Authority
ES
Spain
Prior art keywords
purgant
watery
colon
formulates
additional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96915636T
Other languages
English (en)
Inventor
Craig A Aronchick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27170740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2196149(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2196149T3 publication Critical patent/ES2196149T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE DESCRIBEN FORMULADOS PURGANTES COLONICOS ADMINISTRADOS POR VIA ORAL Y PROCEDIMIENTOS PARA SU UTILIZACION PARA LLEVAR A CABO LA PURGACION PARCIAL O COMPLETA DEL COLON EN MAMIFEROS, CONSISTIENDO LOS FORMULADOS EN MEZCLAS NO ACUOSAS DE FOSFATO DE SODIO MONOBASICO, DIBASICO Y TRIBASICO, ADMINISTRADOS EN FORMA DE COMPRIMIDOS O CAPSULAS EN CONCENTRACIONES DESDE 0,01 A 0,85 GRAMOS POR KILOGRAMO DE PESO CORPORAL. LAS REALIZACIONES PREFERIDAS INCLUYEN LA ADICION DE LIGANTES, DISPERSANTES Y TAMPONES QUE NO AFECTEN DE FORMA ADVERSA LA OSMOLALIDAD O EFICACIA DE LOS FORMULADOS PURGANTES.
ES96915636T 1996-05-08 1996-05-08 Preparaciones purgantes no acuosas para el colon. Expired - Lifetime ES2196149T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002241445A CA2241445C (en) 1996-05-08 1996-05-08 Non-aqueous colonic purgative formulations
PCT/US1996/006563 WO1997041838A1 (en) 1996-05-08 1996-05-08 Non-aqueous colonic purgative formulations
US08/669,834 US5616346A (en) 1993-05-18 1996-06-26 Non-aqueous colonic purgative formulations

Publications (1)

Publication Number Publication Date
ES2196149T3 true ES2196149T3 (es) 2003-12-16

Family

ID=27170740

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96915636T Expired - Lifetime ES2196149T3 (es) 1996-05-08 1996-05-08 Preparaciones purgantes no acuosas para el colon.

Country Status (8)

Country Link
US (1) US5616346A (es)
EP (1) EP0858326B1 (es)
AT (1) ATE235894T1 (es)
CA (1) CA2241445C (es)
DE (1) DE69627170T2 (es)
DK (1) DK0858326T3 (es)
ES (1) ES2196149T3 (es)
WO (1) WO1997041838A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN634595A0 (en) * 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
US6103268A (en) * 1995-11-03 2000-08-15 Borody; Thomas Julius Administering osmotic colonic evacuant containing a picosulfate
ATE201824T1 (de) * 1996-11-13 2001-06-15 Cb Fleet Co Inc Darmreiniger auf basis von umhülltem natriumphosphat
US6162464A (en) * 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
US6447763B1 (en) * 1998-06-12 2002-09-10 Ian L. Gordon Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US20160184358A9 (en) * 2002-07-15 2016-06-30 George M. Halow Bowel cleansing composition
US8361452B2 (en) * 2002-07-15 2013-01-29 Halow George M Bowel cleansing composition
US7291324B2 (en) * 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
US6996500B2 (en) * 2002-10-30 2006-02-07 Hewlett-Packard Development Company, L.P. Method for communicating diagnostic data
US7049319B2 (en) 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
AU2015221520B2 (en) * 2003-11-19 2017-06-08 Salix Pharmaceuticals, Inc. Colonic purgative composition with soluble binding agent
PL1750702T3 (pl) 2004-06-04 2011-04-29 Braintree Laboratories Inc Metoda oczyszczania jelita
US20060051428A1 (en) * 2004-09-03 2006-03-09 Nelson Ayala Aspartame and citrate flavored phosphate salt laxative
US20070082061A1 (en) * 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
JP2009521994A (ja) * 2005-12-29 2009-06-11 ブレーントリー ラボラトリーズ インコーポレーティッド 仮想結腸内視鏡検査を目的として結腸を準備するための、浸透圧性緩下薬および刺激性緩下薬を含むキット
US7985429B2 (en) 2006-03-03 2011-07-26 C. B. Fleet Company, Inc. Flavored colonic cleansing system
US7998510B2 (en) 2006-08-17 2011-08-16 C. B. Fleet Company, Inc. Low dose colonic cleansing system
WO2010123901A1 (en) 2009-04-21 2010-10-28 Bachwich Dale R Colon lavage system
US8211417B1 (en) 2009-10-31 2012-07-03 Harry Snady Method of bowel cleansing
CN102178694B (zh) * 2011-05-06 2013-03-20 四川健能制药有限公司 磷酸钠盐液体制剂
EP3563838A1 (en) 2013-03-15 2019-11-06 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of suflate salts and methods of use thereof
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB917456A (en) * 1958-10-30 1963-02-06 Casco Lab Inc Suppository composition and preparation thereof
US3088870A (en) * 1958-11-25 1963-05-07 Mcdermott Charles Byron Low volume contact laxative enema compositions
US3676553A (en) * 1969-12-15 1972-07-11 Cybersol Therapeutic composition
US3821368A (en) * 1971-06-01 1974-06-28 Cybersal Inc Therapeutic composition
ES8504625A2 (es) * 1972-07-19 1985-05-16 Fisons Iberica S A Mejoras introducidas en el objeto de la patente principal, para: procedimiento para la obtencion de una solucion hipertonica tamponada
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4665100A (en) * 1981-03-13 1987-05-12 Eli Lilly And Company Process for formulating a synthetic drug for use in animal feed, and resulting formulation
US4452779A (en) * 1982-02-03 1984-06-05 Cockerill Vernon Composition and method of treating lactating mammals
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US4812311A (en) * 1984-12-21 1989-03-14 The Procter & Gamble Company Kit for use in the treatment of osteoporosis
US4842871A (en) * 1985-08-01 1989-06-27 Pioneer Hi-Bred International, Inc. Method and inoculant for preserving agricultural products for animal feed
US4904474A (en) * 1988-01-25 1990-02-27 Alza Corporation Delivery of drug to colon by oral disage form
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
IT1229568B (it) * 1989-04-17 1991-09-04 Giuliani Spa Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
US5498425A (en) * 1995-03-17 1996-03-12 Block Drug Company, Inc. Phosphosoda buffered saline laxative

Also Published As

Publication number Publication date
EP0858326A1 (en) 1998-08-19
EP0858326A4 (en) 1999-09-29
CA2241445A1 (en) 1997-11-13
EP0858326B1 (en) 2003-04-02
DK0858326T3 (da) 2003-07-07
CA2241445C (en) 2001-07-31
DE69627170D1 (de) 2003-05-08
WO1997041838A1 (en) 1997-11-13
ATE235894T1 (de) 2003-04-15
DE69627170T2 (de) 2004-03-04
US5616346A (en) 1997-04-01

Similar Documents

Publication Publication Date Title
ES2196149T3 (es) Preparaciones purgantes no acuosas para el colon.
AR025444A1 (es) Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos
HK35597A (en) New phospholipid derivatives of nucleosides their preparation and their use as antiviral drugs
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
PA8442001A1 (es) Derivados de pirimidina biciclica condensada
ES2161290T3 (es) Derivados de quinazolina.
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
ES2185711T3 (es) 1,4-benzotiazepina-1,1-dioxidoshipolipimemicos.
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
SV1998000029A (es) Compuestos de pirazina ref. pg3186
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
PA8452001A1 (es) Derivados de macrolidos c-4" sustituidos
TR199800653T1 (xx) Farmas�tik anjiyostatik dipeptid kompozisyonlar� ve bunlar�n kullan�lmas�na y�nelik metodlar.
ES2091689T3 (es) Aplicacion de la carbamazepina y de la oxcarbazepina en el tratamiento de la enfermedad de parkinson y de los sindromes parkinsonianos.
IL85870A (en) Controlled release pharmaceutical compositions for oral administration containing 3'-azido-3'-deoxythymidine
ES2083668T5 (es) Combinaciones antiviricas que contienen analogos de nucleosido.
CO5070569A1 (es) Compuesto de aminoazol o una sal farmaceuticamente aceptable del mismo y medicamento que los contienen
ES2020171T3 (es) Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.
UY25356A1 (es) Polisacaridos de sintesis,procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
SE8102456L (sv) Farmaceutisk komposition for oral administering och innehallande cytidindifosfokolin
ES2054650T3 (es) Fenilacetonitrilos basicamente substituidos, su obtencion y medicamentos que los contienen.
ES2195158T3 (es) Amidas de alfa-aminoacidos, su preparacion y el uso terapeutico de las mismas.
MX171542B (es) Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas
AR017664A1 (es) Formulaciones farmaceuticas de liberacion sostenida que contienen inhibidores de la alfa-glucosidasa y su uso para la manufactura de un medicamento